The pharmaceutical industry is rapidly restructuring and going through tidal wave of changes in its drug discovery process. The businesses are opting for a model which is fully integrated and networked R&D.

New York, NY -- (SBWire) -- 06/20/2016 --The pharmaceutical industry is rapidly restructuring and going through tidal wave of changes in its drug discovery process. The businesses are opting for a model which is fully integrated and networked R&D. Increasing number of stages in the drug discovery process are being conducted through external collaborators and contract research organizations (CROs). Such rapid restructuring represents great challenges in implementation of the systems required for a collaborative research, and to further ensure that these networks operate efficiently, augment innovation, and at the same time lower the cost of drug discovery. Cloud-based drug discovery platforms are exclusively designed to help drug discovery companies to overcome the major hurdle of data, which has been created due to the fundamental restructuring of their research businesses.

Request TOC (table of content), Figures and Tables of the Report: http://www.persistencemarketresearch.com/toc/11020

Cloud-Based Drug Discovery Platform Market: Drivers & Restraints

Cloud-based computing is a way to help pharmaceutical researchers across the globe to form effective drug discovery teams without large investments in technology, computing resources or fixed running costs. The cloud-based platforms substantially reduces the overall time required in the drug discovery process. Toxicity prediction of a newly discovered drug is one of the restraints in the drug discovery process. Despite decades of unmatched funding by institutions, scientists are still facing problems in predicting the potent toxic side effects of a particular drug. The global cloud-based drug discovery platform market could be adversely affected by the huge investment requirements in the technical infrastructure for the identification of compounds that will cause a desired, optimum biological effect.

Cloud-Based Drug Discovery Platform Market: Segmentation

The global cloud-based drug discovery platform market is classified on the basis of region.

Cloud-Based Drug Discovery Platform Market: Overview

Scientists worldwide are attempting to discover newer drugs for treatment of more and more diseases than ever before. Currently, the drug discovery procedure involves identification of likely candidates, screening them to test biologically active and effective compounds. Discovery of a promising drug candidate quickly is a technical challenge for scientific researchers. But companies such as Microsoft Research have discovered a technological solution to this issue, a cloud-based drug discovery platform Molplex Clouds Against Disease. The company has used their computational platform deployed in the cloud to select 100 compounds from a trillion possible chemical structures which had the potential to be powerful drug agents against antibiotic-resistant bacteria. From these findings, the lab results provided 10 candidate structures with effective biological activity, further unveiling opportunities to treat a new type of antibiotic-resistant bacteria.

Cloud-Based Drug Discovery Platform Market: Region wise Overview

Geographically, global cloud-based drug discovery platform market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan, Middle East and Africa (MEA). Cloud-based drug discovery platform provides researchers an access to a state-of-the-art corporate data centre, wherein huge amount of data can be analysed efficiently. Global cloud-based drug discovery platform market is in its growth phase and its adoption is gaining momentum. Cloud-based drug discovery platform providers are accumulated in the U.S., U.K., Canada and few other European countries. As a result, North America and Europe regions are expected to account for more than half the share in the cloud-based drug discovery platform market.

Cloud-Based Drug Discovery Platform Market: Key Players

The key players in global cloud-based drug discovery platform market are Microsoft, BIOVIA, AstraZeneca, Accenture, Collaborative Drug Discovery, Inc., BioXcel Corporation, twoXAR, Incorporated, Seven Bridges, IBM to name a few. A major trend witnessed in the global cloud-based drug discovery platform is collaborations, particularly of drug discovery companies, universities, software and research companies, cloud management companies and so on. Such collaborative partnerships are enabling drug discovery companies to develop clouds against diseases while offering a high-quality drug discovery service based on a new molecular discovery platform that associates its power from cloud computing.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, accessories and applications.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

Regional analysis includes

North America (U.S., Canada)
Latin America (Brazil, Rest Of Latin America)
Western Europe (Germany, Italy, France, U.K, Spain, Rest Of Western Europe)
Eastern Europe (Russia, Rest Of Eastern Europe)
Asia Pacific (China, India, ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC countries, S. Africa and Rest Of MEA)

To Buy this Full Report: http://www.persistencemarketresearch.com/checkout/11020

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Key points covered in the report

1) Report segments the market on the basis of types, application, products, technology, etc (as applicable)

2) The report covers geographic segmentation
North America
Europe
Asia
RoW

3) The report provides the market size and forecast for the different segments and geographies for the period of 2010 to 2020

4) The report provides company profiles of some of the leading companies operating in the market

5) The report also provides porters five forces analysis of the market.-

PMR for Journalist: http://www.persistencemarketresearch.com/page/journalist-resources.asp

About Persistence Market Research
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.